Linda M. Sinagra
Rome, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Non-Invasive Imaging in Diagnosis and Monitoring of Favre-Racouchot Disease.
Journal: International journal of dermatology
Published: March 06, 2026
Linagliptin is a risk factor for bullous pemphigoid associated with BP180-NC16A/BP230 seronegativity and milder severity: Evidence from a prospective case-control study supporting ECD-BP180 enzyme-linked immunosorbent assay in reducing diagnostic delay.
Journal: Journal of the American Academy of Dermatology
Published: February 16, 2026
Distinctive Reactivity to the C-terminal Epitope of BP180 Characterizes Immune Checkpoint Inhibitor-associated Bullous Pemphigoid, and an ELISA Based on the BP180 Ectodomain Enables Prompt Diagnosis in a Subset of Patients.
Journal: Acta dermato-venereologica
Published: January 09, 2026
Distinctive Reactivity to the C-terminal Epitope of BP180 Characterizes Immune Checkpoint Inhibitor-associated Bullous Pemphigoid, and an ELISA Based on the BP180 Ectodomain Enables Prompt Diagnosis in a Subset of Patients.
Journal: Acta dermato-venereologica
Published: January 09, 2026
Pemphigus: trigger and predisposing factors.
Journal: Frontiers in medicine
Published: October 23, 2023
Autoimmune bullous diseases during COVID-19 pandemic: 2022 update on rituximab and vaccine.
Journal: Frontiers in medicine
Published: November 30, 2022
Bullous Pemphigoid: Trigger and Predisposing Factors.
Journal: Biomolecules
Published: September 07, 2020
Pemphigus vulgaris in two pairs of siblings from two unrelated Italian families: Human leukocyte antigen genotypes, ST18 mutation and immunological profile.
Journal: The Journal of dermatology
Published: July 13, 2020
Mycobacterium abscessus hand-and-foot disease in children: rare or emerging disease?
Journal: Pediatric dermatology
Published: April 25, 2014
Showing 1-9 of 9
Last Updated: 09/26/2026